These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2459580)

  • 1. Differentiation of human tumors from nonmalignant tissue by natural-abundance 13C NMR spectroscopy.
    Halliday KR; Fenoglio-Preiser C; Sillerud LO
    Magn Reson Med; 1988 Aug; 7(4):384-411. PubMed ID: 2459580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decrease in 1H nuclear magnetic resonance spectroscopically determined citrate in human seminal fluid accompanies the development of prostate adenocarcinoma.
    Averna TA; Kline EE; Smith AY; Sillerud LO
    J Urol; 2005 Feb; 173(2):433-8. PubMed ID: 15643195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro proton spectroscopy of normal and abnormal prostate.
    Yacoe ME; Sommer G; Peehl D
    Magn Reson Med; 1991 Jun; 19(2):429-38. PubMed ID: 1715505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo 13C NMR spectroscopy of the human prostate.
    Sillerud LO; Halliday KR; Griffey RH; Fenoglio-Preiser C; Sheppard S
    Magn Reson Med; 1988 Oct; 8(2):224-30. PubMed ID: 2463457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.
    Cornel EB; Smits GA; Oosterhof GO; Karthaus HF; Deburyne FM; Schalken JA; Heerschap A
    J Urol; 1993 Dec; 150(6):2019-24. PubMed ID: 7693985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadband proton decoupled natural abundance 13C NMR spectroscopy of humans at 1.5 T.
    Heerschap A; Luyten PR; van der Heyden JI; Oosterwaal LJ; den Hollander JA
    NMR Biomed; 1989 Sep; 2(3):124-32. PubMed ID: 2641301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
    Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
    Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic characterization of human prostate tissue with proton MR spectroscopy.
    Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C
    Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A versatile multinuclear probe designed for in vivo NMR spectroscopy: applications to subcutaneous human tumors in mice.
    Lyon RC; Tschudin RG; Daly PF; Cohen JS
    Magn Reson Med; 1988 Jan; 6(1):1-14. PubMed ID: 3352500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and structure of triacylglycerols in rat epididymal fat pad adipocytes determined by 13C nuclear magnetic resonance.
    Sillerud LO; Han CH; Bitensky MW; Francendese AA
    J Biol Chem; 1986 Apr; 261(10):4380-8. PubMed ID: 3957902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural abundance 13C NMR spectra of human muscle, normal and diseased.
    Bárány M; Doyle DD; Graff G; Westler WM; Markley JL
    Magn Reson Med; 1984 Mar; 1(1):30-43. PubMed ID: 6571435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prostate and other cancers by two-dimensional protein electrophoresis.
    Anderson KM
    Prostate; 1985; 6(1):101-16. PubMed ID: 2578657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
    García-Segura JM; Sánchez-Chapado M; Ibarburen C; Viaño J; Angulo JC; González J; Rodríguez-Vallejo JM
    Magn Reson Imaging; 1999 Jun; 17(5):755-65. PubMed ID: 10372529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic changes in undifferentiated and differentiated human colon adenocarcinoma cells studied by multinuclear magnetic resonance spectroscopy.
    Galons JP; Fantini J; Vion-Dury J; Cozzone PJ; Canioni P
    Biochimie; 1989 Aug; 71(8):949-61. PubMed ID: 2553131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR in cancer. X. A malignancy index to discriminate normal and cancerous tissue.
    Koutcher JA; Goldsmith M; Damadian R
    Cancer; 1978 Jan; 41(1):174-82. PubMed ID: 626927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR.
    Fowler AH; Pappas AA; Holder JC; Finkbeiner AE; Dalrymple GV; Mullins MS; Sprigg JR; Komoroski RA
    Magn Reson Med; 1992 May; 25(1):140-7. PubMed ID: 1375702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13C- and 31P-NMR studies of human colon cancer in-vitro and in-vivo.
    Singer S; Okunieff P; Gostin C; Thilly WG; Chen LB; Neuringer LJ
    Surg Oncol; 1993; 2(1):7-18. PubMed ID: 8252195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and localization of two distinct microenvironments for the diacylglycerol component of lipophorin particles by 13C NMR.
    Wang J; Liu H; Sykes BD; Ryan RO
    Biochemistry; 1995 May; 34(20):6755-61. PubMed ID: 7756306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer.
    van der Graaf M; Schipper RG; Oosterhof GO; Schalken JA; Verhofstad AA; Heerschap A
    MAGMA; 2000 Jul; 10(3):153-9. PubMed ID: 10873205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions.
    Lynch MJ; Masters J; Pryor JP; Lindon JC; Spraul M; Foxall PJ; Nicholson JK
    J Pharm Biomed Anal; 1994 Jan; 12(1):5-19. PubMed ID: 8161606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.